NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors
The pathogenesis of many rare tumor types is poorly understood, preventing the design of effective treatments. For some of these tumors, the discovery of gene fusion events and the characterization of their biological repercussions has led to the design of …